Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by canadapieton Nov 06, 2020 2:47am
94 Views
Post# 31849817

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Merck buys Velosbio

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Merck buys Velosbio What??????????!!!!!!!! 

I have never ever heard such "a &"#:" reason for a low share price !!!!!!!!

They can start with: 
1) better execute 
2) more visibility 
3) making deals with BP 
4) Insider buying (they hold a "sh...y" amount of shares) 
5) IR has to do "a job"
6) CFO has to do "a job"
7)
8)
etc etc etc 

It is unheard that they should blame whoever for whatever reason for the low share price, while they 'the BOARD, Management" hold such miniscule % of shares!!!! (how much is the float anyway???........) 

But hey, like i have said many times before, they are a company of "hope" ..........
For the moment, there are far more better biotechs to invest in ! 

Still for anyone invested, good luck, you all deserve it (what a patience one can have......) 
Bullboard Posts